Seattle, Washington
United States
18
2026-02-19
The entities that hold a legal rights for patent applications filed by inventor Gray Patrick:
Patrick Gray from Seattle, US has applied for patents for these inventions. The list has both pending applications and granted patents:
Compositions and Methods of Inhibiting MASP-1 and/or MASP-2 and/or MASP-3 for the Treatment of Various Diseases and Disorders
#2 | 2026-02-05Compositions and Methods of Inhibiting MASP-1 and/or MASP-2 and/or MASP-3 for the Treatment of Various Diseases and Disorders
#3 | 2025-04-17Methods of Generating Bioactive Peptide-bearing Antibodies and Compositions Comprising the Same
#4 | 2024-08-01Compositions and Methods of Inhibiting MASP-1 and/or MASP-2 and/or MASP-3 for the Treatment of Various Diseases and Disorders
#5 | 2022-08-18Compositions and Methods of Inhibiting MASP-1 and/or MASP-2 and/or MASP-3 for the Treatment of Various Diseases and Disorders
#6 | 2021-03-18Methods of Generating Bioactive Peptide-bearing Antibodies and Compositions Comprising the Same
#7 | 2019-06-20USE OF PDE7 INHIBITORS FOR THE TREATMENT OF MOVEMENT DISORDERS
#8 | 2019-05-02Compositions and Methods of Inhibiting MASP-1 and/or MASP-2 and/or MASP-3 for the Treatment of Various Diseases and Disorders
#9 | 2017-08-31Methods of generating bioactive peptide-bearing antibodies and compositions comprising the same
#10 | 2016-01-21USE OF PDE7 INHIBITORS FOR THE TREATMENT OF MOVEMENT DISORDERS
#11 | 2015-01-15Methods of Generating Bioactive Peptide-bearing Antibodies and Compositions Comprising the Same
#12 | 2014-12-11Methods of Generating Bioactive Peptide-bearing Antibodies and Compositions Comprising the Same
#13 | 2014-06-26Use of PDE7 inhibitors for the treatment of movement disorders
#14 | 2013-12-26Compositions and Methods of Inhibiting MASP-1 and/or MASP-2 and/or MASP-3 for the Treatment of Various Diseases and Disorders
#15 | 2011-04-21USE OF PDE7 INHIBITORS FOR THE TREATMENT OF MOVEMENT DISORDERS
#16 | 2010-05-06Use of PDE7 inhibitors for the treatment of movement disorders
#17 | 2008-10-23USE OF PDE7 INHIBITORS FOR THE TREATMENT OF MOVEMENT DISORDERS
#18 | 2005-05-12Platelet-activating factor acetylhydrolase
585935 ⎘